Joseph M. Fitzgerald
Net Worth

Last updated:

What is Joseph M. Fitzgerald net worth?

The estimated net worth of Mr. Joseph M. Fitzgerald is at least $51,893,746 as of 7 Oct 2024. He owns shares worth $16,678,940 as insider, has earned $29,154,806 from insider trading and has received compensation worth at least $6,060,000 in Boston Scientific Corporation and Pure Storage, Inc..

What is the salary of Joseph M. Fitzgerald?

Mr. Joseph M. Fitzgerald salary is $1,010,000 per year as Executive Vice President & Pres of Interventional Cardiology in Boston Scientific Corporation.

How old is Joseph M. Fitzgerald?

Mr. Joseph M. Fitzgerald is 61 years old, born in 1964.

What stocks does Joseph M. Fitzgerald currently own?

As insider, Mr. Joseph M. Fitzgerald owns shares in one company:

Company Title Shares Price per share Total value
Boston Scientific Corporation (BSX) Executive Vice President & Pres of Interventional Cardiology 160,467 $103.94 $16,678,940

What does Boston Scientific Corporation do?

Boston Scientific Corporation develops, manufactures, and markets medical devices for use in various interventional medical specialties worldwide. It operates through three segments: MedSurg, Rhythm and Neuro, and Cardiovascular. The company offers devices to diagnose and treat gastrointestinal and pulmonary conditions; devices to treat various urological and pelvic conditions; implantable cardioverter and implantable cardiac resynchronization therapy defibrillators; pacemakers and implantable cardiac resynchronization therapy pacemakers; and remote patient management systems. It also provides medical technologies to diagnose and treat rate and rhythm disorders of the heart comprising 3-D cardiac mapping and navigation solutions, ablation catheters, diagnostic catheters, mapping catheters, intracardiac ultrasound catheters, delivery sheaths, and other accessories; spinal cord stimulator systems for the management of chronic pain; indirect decompression systems; and deep brain stimulation systems. In addition, the company offers interventional cardiology products, including drug-eluting coronary stent systems used in the treatment of coronary artery disease; percutaneous coronary interventions products to treat atherosclerosis; intravascular catheter-directed ultrasound imaging catheters, fractional flow reserve devices, and systems for use in coronary arteries and heart chambers, as well as various peripheral vessels; and structural heart therapies. Further, it provides stents, balloon catheters, wires, and atherectomy systems to treat arterial diseases; thrombectomy and acoustic pulse thrombolysis systems, wires, and stents to treat venous diseases; and peripheral embolization devices, radioactive microspheres, ablation systems, cryotherapy ablation systems, and micro and drainage catheters to treat cancer. The company was incorporated in 1979 and is headquartered in Marlborough, Massachusetts.

BSX logo
BSX
Boston Scientific Corporation
$103.94

Joseph M. Fitzgerald insider trading

Boston Scientific Corporation

Mr. Joseph M. Fitzgerald has made 11 insider trades between 2019-2024, according to the Form 4 filled with the SEC.

The largest trade he's ever made was exercising 132,527 units of BSX stock on 7 Oct 2024. As of 7 Oct 2024 he still owns at least 160,467 units of BSX stock.

Transaction Date Security Shares Price per share Total value Source
Option
Common Stock 57,618 $24.98 $1,439,298
Option
Stock Option (Right to Buy) 116,639 $21.12 $2,463,416
Option
Common Stock 59,021 $17.26 $1,018,702
Sale
Common Stock 132,527 $85 $11,264,928
Sale
Common Stock 14,132 $80 $1,130,560
Sale
Common Stock 11,660 $60 $699,600
Option
Performance Share Units 21,799 N/A N/A
Option
Common Stock 21,799 N/A N/A
Option
Stock Option (Right to Buy) 58,189 $16.31 $949,063
Sale
Common Stock 81,940 $57.5 $4,711,550
Option
Common Stock 58,189 $16.31 $949,063
Sale
Common Stock 15,867 $55 $872,685
Option
Stock Option (Right to Buy) 56,921 $13.08 $744,527
Sale
Common Stock 63,339 $53.6 $3,394,844
Option
Common Stock 56,921 $13.08 $744,527
Option
Common Stock 3,895 N/A N/A
Option
Deferred Stock Units 3,895 N/A N/A
Option
Common Stock 3,706 N/A N/A
Option
Common Stock 4,166 N/A N/A
Option
Common Stock 3,960 N/A N/A
Option
Common Stock 3,603 N/A N/A
Option
Deferred Stock Units 3,603 N/A N/A
Option
Common Stock 3,895 N/A N/A
Option
Deferred Stock Units 3,895 N/A N/A
Option
Common Stock 3,706 N/A N/A
Option
Deferred Stock Units 3,706 N/A N/A
Option
Restricted Stock Units 4,166 N/A N/A
Option
Common Stock 4,166 N/A N/A
Option
Deferred Stock Units 4,614 N/A N/A
Option
Common Stock 4,614 N/A N/A
Option
Performance Share Units 14,035 N/A N/A
Option
Common Stock 14,035 N/A N/A
Sale
Common Stock 105,490 $45 $4,747,366
Option
Stock Option (Right to Buy) 70,306 $6.28 $441,522
Option
Common Stock 70,306 $6.28 $441,522
Option
Common Stock 3,603 N/A N/A
Option
Deferred Stock Units 3,603 N/A N/A
Option
Common Stock 4,056 N/A N/A
Option
Deferred Stock Units 4,056 N/A N/A
Option
Deferred Stock Units 3,894 N/A N/A
Option
Common Stock 3,894 N/A N/A
Option
Deferred Stock Units 3,706 N/A N/A
Option
Common Stock 3,706 N/A N/A
Option
Deferred Stock Units 4,614 N/A N/A
Option
Common Stock 4,614 N/A N/A
Option
Performance Share Units 27,199 N/A N/A
Option
Common Stock 27,199 N/A N/A
Option
Common Stock 77,640 $7.16 $555,902
Option
Stock Option (Right to Buy) 77,640 $7.16 $555,902
Sale
Common Stock 77,640 $7.16 $555,902
Option
Common Stock 3,603 N/A N/A
Option
Deferred Stock Units 3,603 N/A N/A
Option
Deferred Stock Units 4,139 N/A N/A
Option
Common Stock 4,139 N/A N/A
Option
Common Stock 4,056 N/A N/A
Option
Deferred Stock Units 4,056 N/A N/A
Option
Deferred Stock Units 3,894 N/A N/A
Option
Common Stock 3,894 N/A N/A
Option
Deferred Stock Units 4,614 N/A N/A
Option
Common Stock 4,614 N/A N/A
Option
Common Stock 17,582 N/A N/A
Option
Performance Share Units 17,582 N/A N/A
Option
Stock Option (Right to Buy) 107,692 $7.41 $797,998
Option
Common Stock 107,692 $7.41 $797,998
Sale
Common Stock 107,692 $7.41 $797,998
Sale
Common Stock 20,673 $43.41 $897,415
Sale
Common Stock 1,906 $43 $81,958
Option
Deferred Stock Units 3,603 N/A N/A
Option
Common Stock 3,603 N/A N/A

Boston Scientific key executives

Boston Scientific Corporation executives and other stock owners filed with the SEC: